MAIMX
Price
$26.25
Change
-$0.17 (-0.64%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

MAIMX vs VMVAX

Header iconMAIMX vs VMVAX Comparison
Open Charts MAIMX vs VMVAXBanner chart's image
Victory Integrity Mid-Cap Value A
Price$26.25
Change-$0.17 (-0.64%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MAIMX vs VMVAX Comparison Chart
Loading...
VS
MAIMX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAIMX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. MAIMX (326M). VMVAX pays higher dividends than MAIMX: VMVAX (2.14) vs MAIMX (0.34). MAIMX was incepted earlier than VMVAX: MAIMX (13 years) vs VMVAX (13 years). MAIMX is a more actively managed with annual turnover of: 57.00 vs. VMVAX (22.00). MAIMX has a lower initial minimum investment than VMVAX: MAIMX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. MAIMX (21.50). MAIMX (48.93) and VMVAX (48.82) have equivalent 5 years return.
MAIMXVMVAXMAIMX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD14.07614.94694%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets326M30.5B1%
Annual Yield % from dividends0.342.1416%
Returns for 1 year21.5025.3585%
Returns for 3 years18.0820.7187%
Returns for 5 years48.9348.82100%
Returns for 10 years80.40100.8880%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio